SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $528,039 | +111.2% | 4,075 | +26.6% | 0.00% | 0.0% |
| Q2 2021 | $250,000 | +8.7% | 3,220 | +4.2% | 0.00% | -20.0% |
| Q1 2021 | $230,000 | +72.9% | 3,090 | +273.2% | 0.01% | +25.0% |
| Q2 2020 | $133,000 | -46.6% | 828 | -90.2% | 0.00% | -75.0% |
| Q2 2014 | $249,000 | -3.9% | 8,470 | -22.8% | 0.02% | -15.8% |
| Q1 2014 | $259,000 | +16.7% | 10,975 | -0.5% | 0.02% | +11.8% |
| Q4 2013 | $222,000 | -75.1% | 11,025 | -42.0% | 0.02% | -77.9% |
| Q3 2013 | $893,000 | +5.8% | 19,005 | -13.9% | 0.08% | -8.3% |
| Q2 2013 | $844,000 | +17.5% | 22,080 | +12.8% | 0.08% | +15.1% |
| Q1 2013 | $718,000 | – | 19,575 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |